Products for Research Use Only

Lanopepden camsylate

CAT: 0931-T70642-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T70642-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1441390-28-8
Target
Others
Related Pathways
Others
Bioactivity
Lanopepden, also known as GSK-1322322 or GSK-322, is a potent and selective peptide deformylase inhibitor with good in vitro activity against bacteria associated with community-acquired pneumonia and skin infections. GSK1322322 had bactericidal activity against S. pneumoniae, H. influenzae, S. pyogenes, and S. aureus, demonstrating a ≥ 3-log (10) decrease in the number of CFU/ml at 4x MIC within 24 h in 29 of the 33 strains tested. GSK1322322 represents a valuable alternative therapy for the treatment of infectious diseases caused by drug-resistant pathogens.
Smiles
CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2.[H][C@]12COCCN1CCN(C2)c1nc(C)nc(NNC(=O)[C@H](CC2CCCC2)CN(O)C=O)c1F
Molecular Formula
C32H50FN7O8S
Molecular Weight
711.8514
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide;(7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl)methanesulfonic acid
CAS Number1441390-28-8
PubChem CID159683027
IUPAC NameN-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide;(7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl)methanesulfonic acid
Molecular FormulaC32H50FN7O8S
Molecular Weight711.8
Topological Polar Surface Area203
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count14
Rotatable Bond Count10
Heavy Atom Count49
Formal Charge0
Complexity1090
SMILES
CC1=NC(=C(C(=N1)N2CCN3CCOC[C@@H]3C2)F)NNC(=O)[C@H](CC4CCCC4)CN(C=O)O.CC1(C2CCC1(C(=O)C2)CS(=O)(=O)O)C
InChI
InChI=1S/C22H34FN7O4.C10H16O4S/c1-15-24-20(19(23)21(25-15)29-7-6-28-8-9-34-13-18(28)12-29)26-27-22(32)17(11-30(33)14-31)10-16-4-2-3-5-16;1-9(2)7-3-4-10(9,8(11)5-7)6-15(12,13)14/h14,16-18,33H,2-13H2,1H3,(H,27,32)(H,24,25,26);7H,3-6H2,1-2H3,(H,12,13,14)/t17-,18+;/m1./s1
InChIKey
MVLAZTDMRJUAQK-URBRKQAFSA-N
Chemical Structure
2D Structure
2D structure of N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide;(7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl)methanesulfonic acid
CAS: 1441390-28-8
CID: 159683027
Formula: C32H50FN7O8S
MW: 711.8
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight711.8
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count14
Rotatable Bond Count10
Exact Mass711.34256091
Monoisotopic Mass711.34256091
Topological Polar Surface Area203 Ų
Heavy Atom Count49
Formal Charge0
Complexity1090
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes